ClinicalTrials.govpublic full text
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age
infections, meningococcal
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 628569
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.